{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:44:50Z","timestamp":1772167490062,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018268","name":"Children's Miracle Network Hospitals","doi-asserted-by":"publisher","award":["140032"],"award-info":[{"award-number":["140032"]}],"id":[{"id":"10.13039\/100018268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011599","name":"Penn State Health Children's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011599","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.cct.2022.106937","type":"journal-article","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T11:28:22Z","timestamp":1664018902000},"page":"106937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["An experimental protocol for a double-blind placebo-controlled evaluation of the effectiveness of oral naltrexone in management of adolescent eating disorders"],"prefix":"10.1016","volume":"122","author":[{"given":"Rosemary Claire","family":"Roden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marley","family":"Billman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Lane-Loney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamal","family":"Essayli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fauzia","family":"Mahr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kent","family":"Vrana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheryl","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2022.106937_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders","first-page":"329","article-title":"Feeding and eating disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.cct.2022.106937_bb0010","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/eat.22596","article-title":"Transitioning from DSM-IV to DSM-5: a systematic review of eating disorder prevalence assessment","volume":"49","author":"Lindvall Dahlgren","year":"2016","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.cct.2022.106937_bb0015","series-title":"The Changing Demographic Profile of Eating Disorder Behaviors in the Community","author":"Mitchison","year":"2014"},{"key":"10.1016\/j.cct.2022.106937_bb0020","article-title":"CLINICAL REPORT guidance for the clinician in rendering pediatric care identification and management of eating disorders in children and adolescents","volume":"147","author":"Hornberger","year":"2021","journal-title":"PediatricsPediatrics"},{"key":"10.1016\/j.cct.2022.106937_bb0025","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1542\/peds.2014-0194","article-title":"Eating disorders in children and adolescents: state of the art review","volume":"134","author":"Campbell","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.cct.2022.106937_bb0030","doi-asserted-by":"crossref","first-page":"E192","DOI":"10.9778\/cmajo.20140086","article-title":"Cost analysis of inpatient treatment of anorexia nervosa in adolescents: hospital and caregiver perspectives","volume":"3","author":"Toulany","year":"2015","journal-title":"C Open"},{"key":"10.1016\/j.cct.2022.106937_bb0035","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/eat.22114","article-title":"A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder","volume":"46","author":"Mcelroy","year":"2013","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.cct.2022.106937_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8020278","article-title":"Medication in AN: a multidisciplinary overview of meta-analyses and systematic reviews","volume":"8","author":"Blanchet","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cct.2022.106937_bb0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/14740338.2018.1395854","article-title":"Safety of pharmacotherapy options for bulimia nervosa and binge eating disorder","volume":"17","author":"Bello","year":"2018","journal-title":"Expert. Oinion. Drug. Saf."},{"key":"10.1016\/j.cct.2022.106937_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ADM.0000000000000089","article-title":"Pharmacotherapy of binge-eating disorder: a review","volume":"9","author":"Goracci","year":"2015","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.cct.2022.106937_bb0055","doi-asserted-by":"crossref","DOI":"10.1007\/s11920-015-0573-1","article-title":"Psychopharmacologic treatment of eating disorders: emerging findings","volume":"17","author":"McElroy","year":"2015","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.cct.2022.106937_bb0060","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2190\/0CMP-4XXH-3641-NRDW","article-title":"Treatment of antidepressant-resistant bulimia with naltrexone","volume":"16","author":"Jonas","year":"1986","journal-title":"Int. J. Psychiatry Med."},{"key":"10.1016\/j.cct.2022.106937_bb0065","series-title":"Revia (Naltrexone Hydrochloride Tablets)","author":"Food and Drug Administration (FDA)","year":"2013"},{"key":"10.1016\/j.cct.2022.106937_bb0070","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/jir.12122","article-title":"Are opioid antagonists effective in attenuating the core symptoms of autism spectrum conditions in children: a systematic review","volume":"59","author":"Roy","year":"2015","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.cct.2022.106937_bb0075","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00004850-199510030-00005","article-title":"Naltrexone use in the treatment of anorexia nervosa and bulimia nervosa","volume":"10","author":"Marrazzi","year":"1995","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.cct.2022.106937_bb0080","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1089\/cap.2019.0056","article-title":"Naltrexone reduces binge eating and purging in adolescents in an eating disorder program","volume":"29","author":"Stancil","year":"2019","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.cct.2022.106937_bb0085","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3109\/15622975.2011.602720","article-title":"World federation of societies of biological psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders","volume":"12","author":"Aigner","year":"2011","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.cct.2022.106937_bb0090","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/eat.22430","article-title":"Development, psychometric properties and preliminary clinical validation of a brief, session-by-session measure of eating disorder cognitions and behaviors: the ED-15","volume":"48","author":"Tatham","year":"2015","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.cct.2022.106937_bb0095","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The columbia\u2013suicide severity rating scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.cct.2022.106937_bb0100","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/archpediatrics.2012.1276","article-title":"Ask suicide-screening questions (ASQ): a brief instrument for the pediatric emergency department","volume":"166","author":"Horowitz","year":"2012","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.cct.2022.106937_bb0105","article-title":"The hidden burden of eating disorders during the COVID-19 pandemic","author":"Taquet","year":"2021","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.cct.2022.106937_bb0110","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jaac.2021.10.022","article-title":"The rise of eating disorders during COVID-19 and the impact on treatment","volume":"61","author":"Reed","year":"2022","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.cct.2022.106937_bb0115","doi-asserted-by":"crossref","DOI":"10.1186\/s40337-021-00419-3","article-title":"The impact of COVID-19 on adolescents with eating disorders: a cohort study","volume":"9","author":"Spettigue","year":"2021","journal-title":"J. Eat. Disord."},{"key":"10.1016\/j.cct.2022.106937_bb0120","doi-asserted-by":"crossref","DOI":"10.1186\/s40337-021-00437-1","article-title":"COVID-19 and eating disorder and mental health concerns in patients with eating disorders","volume":"9","author":"Vitagliano","year":"2021","journal-title":"J. Eat. Disord."},{"key":"10.1016\/j.cct.2022.106937_bb0125","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/eat.23368","article-title":"The impact of COVID-19 epidemic on eating disorders: a longitudinal observation of pre versus post psychopathological features in a sample of patients with eating disorders and a group of healthy controls","volume":"53","author":"Castellini","year":"2020","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.cct.2022.106937_bb0130","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G*power 3.1: tests for correlation and regression analyses","volume":"41","author":"Erdfelder","year":"2009","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.cct.2022.106937_bb0135","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.cct.2022.106937_bb0140","series-title":"Treatment of Binge Eating Disorder in Obesity: Naltrexone\/ Bupropion Combination Versus Placebo","author":"Yale University","year":"2014"},{"key":"10.1016\/j.cct.2022.106937_bb0145","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/mrdd.1410010209","article-title":"Opiate mechanisms in self-injury","volume":"1","author":"Sandman","year":"1995","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.cct.2022.106937_bb0150","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neubiorev.2014.11.007","article-title":"The role of endogenous opioids in non-suicidal self-injurious behavior: methodological challenges","volume":"48","author":"Kirtley","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.cct.2022.106937_bb0155","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0165-1781(95)02601-R","article-title":"Low-dose naltrexone effects on plasma chemistries and clinical symptoms in autism: a double-blind, placebo-controlled study","volume":"58","author":"Bouvard","year":"1995","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.cct.2022.106937_bb0160","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11195-013-9307-7","article-title":"Teachers\u2019 perspectives on sexuality and sexuality education of learners with intellectual disabilities in Nigeria","volume":"32","author":"Aderemi","year":"2014","journal-title":"Sex. Disabil."},{"key":"10.1016\/j.cct.2022.106937_bb0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.14740\/jocmr4066","article-title":"The opioid system and food intake: use of opiate antagonists in treatment of binge eating disorder and abnormal eating behavior","volume":"12","author":"Valbrun","year":"2020","journal-title":"J. Clin. Med. Res."},{"key":"10.1016\/j.cct.2022.106937_bb0170","series-title":"Barriers to Accessing Health Care in Rural Regions by Transgender, Non-Binary, and Gender Diverse People: A Case-Based Scoping Review","volume":"12","author":"Renner","year":"2021"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714422002634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714422002634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:57:42Z","timestamp":1761555462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714422002634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":34,"alternative-id":["S1551714422002634"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2022.106937","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An experimental protocol for a double-blind placebo-controlled evaluation of the effectiveness of oral naltrexone in management of adolescent eating disorders","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2022.106937","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106937"}}